Friday, October 30, 2026 · Edition updated 6:00 AM ETFRI, OCT 30 · 6 AM ET editionNext edition in Next --:--:--

How aging-like cell stress may affect the eye's surface

A summary of earlier studies · International journal of molecular sciences · Oct 27, 2026

What this means

This review summarizes earlier studies on senescence, a state where cells stop dividing and release inflammatory signals. It suggests this state can help or harm the eye's surface, depending on the situation.

Plain-English summary written by an AI model from the abstract. The original is below.

Tested inSummary of earlier studies
Who it was tested in
A review of studies on eye surface disease, including cells in a dish, animals, and some people
Kind of research
A summary of earlier studies

The science

Original title
Cellular Senescence in Ocular Surface Diseases: Molecular Mechanisms and Therapeutic Perspectives.
Authors
Zhang L, Li S, Gao Q et al.
Journal
International journal of molecular sciences
Published
Oct 27, 2026
Study type
Review · in humans

Abstract

Cellular senescence is characterized by stable cell-cycle arrest and a senescence-associated secretory phenotype (SASP). Recurrent desiccating, oxidative, ultraviolet, microbial, and immune-mediated insults may induce stress-induced premature senescence (SIPS) in ocular surface tissues. PubMed and Web of Science were searched from database inception to 30 June 2026. Primary human, animal, and in vitro studies were prioritized, and direct evidence of senescence was distinguished from indirect stress-related or SASP-like associations. The p53-p21CIP1-pRB and p16INK4a-pRB pathways mediate senescence-associated cell-cycle arrest. Reactive oxygen species (ROS)-p38 mitogen-activated protein kinase (p38 MAPK) and cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) signaling act as stress-sensing and inflammatory pathways, whereas mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) contribute to SASP and metabolic regulation. Transient senescence may support wound repair and immune clearance, whereas persistent senescence may contribute to epithelial and endothelial dysfunction, tear-film instability, immune dysregulation, fibrosis, and extracellular matrix remodeling. Mechanistic support is strongest in selected experimental models; evidence in several human ocular surface disorders remains associative. Cellular senescence is a context-dependent contributor to ocular surface pathology. Senolytic and senomorphic strategies remain predominantly preclinical and require disease-, cell-, and stage-specific validation.

Read it on PubMed ↗

Zhang L, Li S, Gao Q et al. Cellular Senescence in Ocular Surface Diseases: Molecular Mechanisms and Therapeutic Perspectives. International journal of molecular sciences. 2026. doi:10.3390/ijms27209003. PMID: 42941778. https://pubmed.ncbi.nlm.nih.gov/42941778/

Related research

Study · JACS Au · Oct 29, 2026

New fluorescent sensor detects cells aging from cancer and lung drugs

Researchers built a glowing probe that lights up only in certain aged cells. It may help scientists track these cells in living animals, but this is early lab work.

Study · Neuro-oncology · Oct 29, 2026

Mixing a senescence-clearing drug with trametinib slowed glioma regrowth in mice

Researchers found a drug combination that cleared aging-like tumour cells in mice and slowed regrowth. This does not show the combination would work the same way in children.

AnimalsStudy · Molecular metabolism · Oct 29, 2026

A vaccine-style treatment in mice eased diabetes signs and aged cell markers

Mice given a treatment aimed at a virus-like gene showed less weight gain and better blood sugar control. This study was in mice and cells, so it does not show the same would happen in people.

Summary of earlier studiesReview · Aging cell · Oct 28, 2026

Aging cells that support stem cells may disrupt them through chemical signals

This is a review that pulls together older and newer studies. It proposes a model, but it does not show that the model is true.

Preprint · bioRxiv · Oct 28, 2026

Cx43 protein may boost breast cancer drug response in lab tests

Researchers studied a protein called Cx43 that helps cells talk to each other. They found it may help a breast cancer drug slow tumor growth. This early work is not yet checked by other scientists, so it does not show this would help people.

Study · Signal transduction and targeted therapy · Oct 28, 2026

Ginseng compound Rb1 eased signs of aging in the uterus in lab tests

Researchers found that Rb1 reduced aging signs in uterus lining cells and mouse uteruses. This does not show Rb1 helps aging uteruses in people.

See all research on Senolytics →

Report a problem